FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment
August 23, 2020 — Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients as part of the agency’s ongoing efforts to fight COVID-19. Based on scientific evidence available, the FDA concluded, as outlined in its decision memorandum, this product may… Read More »